CTNM Contineum Therapeutics, Inc.: institutional ownership and insider trading
113 funds reported holding $550M of Contineum Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $88.7K, with 28 new positions and 15 funds selling out; over the last 12 months insiders bought $0 and sold $1.86M on the open market.
CTNM revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$15.2M, EPS -0.40
- Quarter ended Mar 31, 2026: revenue n/a, net income −$14.5M, EPS -0.39
- Quarter ended Dec 31, 2025: revenue n/a, net income −$15.2M
- Quarter ended Sep 30, 2025: revenue n/a, net income −$12.8M
Famous investors holding CTNM
- Izzy Englander (Millennium Management): $15.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $6.50M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.10M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $497K, 0.0% of the portfolio
Largest institutional holders of CTNM
- SUVRETTA CAPITAL MANAGEMENT, LLC — $46.6M
- Jupiter Topco LLC — $44.8M
- JANUS HENDERSON GROUP PLC (JHG) — $35.6M
- BlackRock, Inc. (BLK) — $33.8M
- JOHNSON & JOHNSON (JNJ) — $32.4M
- FRANKLIN RESOURCES INC (BEN) — $30.1M
- BALYASNY ASSET MANAGEMENT L.P. — $25.0M
- VANGUARD CAPITAL MANAGEMENT LLC — $21.7M
- PERCEPTIVE ADVISORS LLC — $20.6M
- FMR LLC — $17.0M
Recent CTNM insider trades
- Sep 8, 2026: Stengone Carmine N. sold 2,500 shares ($41.2K)
- Aug 3, 2026: Stengone Carmine N. sold 2,500 shares ($40.0K)
- Jul 9, 2026: Lorrain Daniel S. sold 1,040 shares ($16.6K)
- Jul 8, 2026: Stengone Carmine N. sold 2,500 shares ($40.0K)
5%+ owners
- BALYASNY ASSET MANAGEMENT L.P.: 7.1% (Schedule 13G/A, filed Aug 14, 2026)
- BlackRock, Inc.: 6.3% (Schedule 13G, filed Jul 27, 2026)
- Trails Edge Capital Partners, LP: 5.1% (Schedule 13G, filed Oct 22, 2026)
Who owns the most CTNM stock?
The largest institutional holders of Contineum Therapeutics, Inc. in the latest 13F filings are SUVRETTA CAPITAL MANAGEMENT, LLC ($46.6M), Jupiter Topco LLC ($44.8M), JANUS HENDERSON GROUP PLC (JHG) ($35.6M).
Are insiders buying or selling CTNM?
Over the last 12 months insiders bought $0 and sold $1.86M of Contineum Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own CTNM?
Izzy Englander, Ken Griffin, Renaissance Technologies, Two Sigma.
Which ETFs hold CTNM?
4 ETFs and mutual funds hold it among their top 100 positions, including FBDIX, FBDIX, FACDX, FBTAX.